← Back
Data updated: Mar 10, 2026
ALVOTECH USA INC
ImmunologyGastroenterology
ALVOTECH USA INC is a biotechnology company focused on Immunology, Gastroenterology.
2024
Since
2
Drugs
-
Trials
17
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
SELARSDI 2025-12-01
SELARSDI 2025-11-19
Labeling
SIMLANDI 2025-11-06
Labeling
SIMLANDI 2025-10-16
SELARSDI 2025-04-30
Supplement
SIMLANDI 2025-04-07
Manufacturing (CMC)
SIMLANDI 2025-04-07
Manufacturing (CMC)
SIMLANDI 2025-02-14
Manufacturing (CMC)
SELARSDI 2025-02-12
Manufacturing (CMC)
SELARSDI 2024-10-18
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Immunology 50%
2 drugs
Gastroenterology 50%
2 drugs
Pipeline Strength Pro
Loading...